Medivation
Navigation Links
Medivation in Medical News
...n the Company's website for 30 days.
About medivation
Medivation, Inc. is a biopharmaceutical co...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ... patients and their caregivers. In September 2008, medivation announced a global agreement with Pfizer Inc to de...
...rease global access to cutting-edge science. medivation recently received written permission from the U.S....reatment options and a poor prognosis. About medivation Medivation, Inc. is a biopharmaceutical company...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ...
...he androgen receptor and DNA binding. About medivation Medivation, Inc. is a biopharmaceutical compan...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ... patients and their caregivers. In September 2008, medivation announced a global agreement with Pfizer Inc to de...
...o the event listing in the Investor section of the medivation website. A replay of the webcast will be availabl...on the Company's website for 30 days. About medivation Medivation, Inc. is a biopharmaceutical compan...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ...
Medivation to Present at 8th Annual Needham Life Sciences Conference
...e Hotel. Dr. Hung will provide an overview of medivation and its clinical development programs for Dimebon ... days following the live presentation. About medivation Medivation, Inc. is a biopharmaceutical com...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ...Medivation Announces Offering of 2,750,000 Shares of Common Stock
...ment (telephone number 718-242-8002). About medivation Medivation, Inc. is a biopharmaceutical compan...s release contains "forward-looking statements" of medivation within the meaning of the federal securities laws....ts that speak only as of the date of this release. medivation undertakes no obligation to update publicly any fo......rease global access to cutting-edge science. medivation recently received written permission from the U.S....reatment options and a poor prognosis. About medivation Medivation, Inc. is a biopharmaceutical company...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ...
Medivation to Present at the Leerink Swann Novel Cancer Therapeutics Roundtable Conference
...ew York. Dr. Hung will provide an overview of medivation and its clinical development programs at 10:30 a.m... days following the live presentation. About medivation Medivation, Inc. is a biopharmaceutical compan...es for which there are limited treatment options. medivation aims to transform the treatment of these diseases ...Medivation Reports First Quarter 2009 Financial Results and Provides Corporate Update
...st quarter of 2009, the true-up payment payable to medivation was $5.8 million. medivation presents these cost-sharing true-up payments in th...expense line of its statement of operations. medivation reported a net loss for the quarter ended March 31...New Prostate Cancer Drug May Hold Promise
... he said. Based on those results, Scher said, an application for a large-scale trial has been submitted to the U.S. Food and Drug Administration by medivation Inc., a California-based biopharmaceutical company that has licensed the drug, now called MDV3100. The hope is that the trial will lead to FDA approva......he androgen receptor and DNA binding. About medivation Medivation, Inc. is a biopharmaceutical compan...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ... patients and their caregivers. In September 2008, medivation announced a global agreement with Pfizer Inc to de...
Medivation Announces Fourth Quarter and Year-End 2008 Teleconference and Webcast on March 16, 2009
...on the Company's website for 30 days. About medivation Medivation, Inc. is a biopharmaceutical company...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ... patients and their caregivers. In September 2008, medivation announced a global agreement with Pfizer Inc to de......o the event listing in the Investor section of the medivation website. A replay of the webcast will be availabl...on the Company's website for 30 days. About medivation Medivation, Inc. is a biopharmaceutical compan...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ...
Medivation in Medical Technology
--New 12-month study broadens Phase 3 clinical program to further evaluate the benefits of Dimebon in Alzheimer's Disease--
NEW YORK and SAN FRANCISCO, April 15 /PRNewswire-FirstCall/ -- Pfizer (NYSE: PFE ) and Medivation, Inc. (Nasdaq: MDVN ) today announced the initiation of a 12-mont...
...ated at doses up to and including 240 mg/day. medivation plans to initiate a pivotal Phase 3 clinical trial...he androgen receptor and DNA binding. About medivation Medivation, Inc. is a biopharmaceutical compan...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ...
...e androgen receptor and DNA binding. About medivation Medivation, Inc. is a biopharmaceutical co...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ... patients and their caregivers. In September 2008, medivation entered into a global agreement with Pfizer Inc to...
...of Action In a podium presentation at ICAD 2008, medivation presented new data on Dimebon's novel mitochondria...ochondrial mechanism of action. On July 7, 2008, medivation announced positive safety and efficacy results fro...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ...
...rates through a novel mitochondrial mechanism of action. On July 7, 2008, medivation announced positive safety and efficacy results from its Phase 2 trial of Di...gs to treat serious diseases for which there are limited treatment options. medivation aims to transform the treatment of these diseases and offer hope to critica...
...pment of novel small molecule drugs to treat serious diseases of the central nervous system and cancers for which there are limited treatment options. medivation aims to revolutionize the treatment of these diseases and offer hope to critically ill patients and their caregivers. The Company's current clinical d...
...-6386). Results of First Pivotal Phase 3 Trial medivation previously announced results from its first pivota...rough a novel mitochondrial mechanism of action. medivation is also evaluating Dimebon in an ongoing Phase 2 c...ers for which there are limited treatment options. medivation aims to revolutionize the treatment of these disea...
...e patients and are also exploring higher doses." medivation expects to complete the study, and report final to...e results, in 2008. If these results are positive, medivation expects to seek U.S. Food and Drug Administration ...ers for which there are limited treatment options. medivation aims to revolutionize the treatment of these disea...
...ity, pharmacokinetics, effects on serum PSA levels and disease progression. medivation expects to complete the study and report final top-line results in 2008. ...l nervous system and cancers for which there are limited treatment options. medivation aims to revolutionize the treatment of these diseases and offer hope to cri...
...ated at doses up to and including 240 mg/day. medivation plans to initiate a pivotal Phase 3 clinical trial...he androgen receptor and DNA binding. About medivation Medivation, Inc. is a biopharmaceutical compan...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ...
...e androgen receptor and DNA binding. About medivation Medivation, Inc. is a biopharmaceutical co...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ... patients and their caregivers. In September 2008, medivation entered into a global agreement with Pfizer Inc to...
...of Action In a podium presentation at ICAD 2008, medivation presented new data on Dimebon's novel mitochondria...ochondrial mechanism of action. On July 7, 2008, medivation announced positive safety and efficacy results fro...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ...
...rates through a novel mitochondrial mechanism of action. On July 7, 2008, medivation announced positive safety and efficacy results from its Phase 2 trial of Di...gs to treat serious diseases for which there are limited treatment options. medivation aims to transform the treatment of these diseases and offer hope to critica...
Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease
...novel mitochondrial mechanism of action. Teleconference/Webcast Details medivation will host a teleconference at 5:00 p.m. Eastern Daylight Time today. To par...gs to treat serious diseases for which there are limited treatment options. medivation aims to improve the treatment of these diseases and offer hope to criticall......pment of novel small molecule drugs to treat serious diseases of the central nervous system and cancers for which there are limited treatment options. medivation aims to revolutionize the treatment of these diseases and offer hope to critically ill patients and their caregivers. The Company's current clinical d...
...-6386). Results of First Pivotal Phase 3 Trial medivation previously announced results from its first pivota...rough a novel mitochondrial mechanism of action. medivation is also evaluating Dimebon in an ongoing Phase 2 c...ers for which there are limited treatment options. medivation aims to revolutionize the treatment of these disea...
...e patients and are also exploring higher doses." medivation expects to complete the study, and report final to...e results, in 2008. If these results are positive, medivation expects to seek U.S. Food and Drug Administration ...ers for which there are limited treatment options. medivation aims to revolutionize the treatment of these disea...
...ity, pharmacokinetics, effects on serum PSA levels and disease progression. medivation expects to complete the study and report final top-line results in 2008. ...l nervous system and cancers for which there are limited treatment options. medivation aims to revolutionize the treatment of these diseases and offer hope to cri...
Medivation in Biological News
New drug shows promise in treating drug-resistant prostate cancer
...pounds were licensed by the pharmaceutical company medivation Inc., which chose to test MDV3100 in clinical tria...e Food and Drug Administration has agreed to allow medivation to begin what Jung described as "the pivotal Phase...eptors. The promising laboratory studies led medivation to license the drugs for commercial development. ...New medications show promise in treating drug-resistant prostate cancer
...cancer cells. The new compounds manufactured by the pharmaceutical company medivation and known as MDV3100 and RD162 appear to work well even in prostate cells ...eptor is present, Sawyers explained. The promising laboratory studies led medivation to license the drugs for commercial development, said Sawyers, who serves a...Medivation in Biological Technology
...ngton disease, a Phase 2 study has been completed. medivation and Pfizer expect to initiate a Phase 3 trial this... well as delusions or hallucinations.
About medivation
Medivation, Inc. is a biopharmaceutical compan...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ...
...CO's 2009 Genitourinary Cancers Symposium - - medivation to Host Conference Call and Webcast Presentation w...state cancer, I am enthusiastic about working with medivation to advance MDV3100 into Phase 3 clinical developme...o the event listing in the Investor section of the medivation website. A replay of the webcast will be availabl...
Medivation Announces Pricing of Public Offering
...ment (telephone number 718-242-8002). About medivation Medivation, Inc. is a biopharmaceutical com...s release contains "forward-looking statements" of medivation within the meaning of the federal securities laws....ts that speak only as of the date of this release. medivation undertakes no obligation to update publicly any fo...Medivation Announces First Quarter 2009 Financial Results Teleconference and Webcast on May 11, 2009
...on the Company's website for 30 days. About medivation Medivation, Inc. is a biopharmaceutical compan...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ... patients and their caregivers. In September 2008, medivation announced a global agreement with Pfizer Inc to de...Medivation Announces Upcoming Scientific Presentations at Medical Conferences
...om currently available AD medications. About medivation Medivation, Inc. is a biopharmaceutical compan...es for which there are limited treatment options. medivation aims to transform the treatment of these diseases ...patients and their caregivers. In September 2008, medivation announced a global agreement with Pfizer Inc to de...Medivation Reports Fourth Quarter and Year-End 2008 Financial Results and Provides Corporate Update
...th quarter of 2008, the true-up payment payable to medivation was $3.5 million. medivation presents these cost-sharing true-up payments in th... expense line of its statement of operations. medivation reported a net loss for the quarter ended December......CO's 2009 Genitourinary Cancers Symposium - - medivation to Host Conference Call and Webcast Presentation w...state cancer, I am enthusiastic about working with medivation to advance MDV3100 into Phase 3 clinical developme...o the event listing in the Investor section of the medivation website. A replay of the webcast will be availabl...
Medivation Presents New Data on Dimebon's Novel Mechanism of Action
... is planned in Huntington's disease. About medivation Medivation, Inc. is a biopharmaceutical co...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ... patients and their caregivers. In September 2008, medivation entered into a global agreement with Pfizer Inc to...Medivation Announces Participation in RBC Capital Markets 2008 Healthcare Conference
...ays following the live presentation. About medivation Medivation, Inc. is a biopharmaceutical co...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ... patients and their caregivers. In September 2008, medivation entered into a global agreement with Pfizer Inc to...Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update
...s diseases. Under the terms of the agreement, medivation has received an up-front cash payment of $225 ...um tolerated dose (MTD) has not been reached. -- medivation expects to seek FDA agreement to begin a pivotal P... 2009. Third Quarter 2008 Financial Results medivation reported a net loss for the quarter ended Septembe...Medivation Announces Third Quarter 2008 Teleconference and Webcast on November 10, 2008
...utical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. The Company's current clinical devel...Other TagsSpecializedDiabeticDiabeticDiabeticMechanismMechanismMechanismProteomicsDepressionDepressionDepressionMorphineMappingMappingMicroRNAsCertainCertainBacterialBacterialBacterialBacterialBacterialRecombinantRecombinantOther Contentsbrainbrainbrainbrainbrainbrainbrainbrainbrainbraincapacitationcancercancercancercancercancercancercancercancercancercancercarbohydratecarbohydratecarbohydratecarbohydratecarbohydratecarbohydratecarbohydratecarbohydratecarnivorecarnivorefixationfixationfixationfixationfixationfixationfixationfixationcarboncarboncarboncarboncarboncarboncarbon
BioinformaticsSpecializedDiabeticMechanismChickadeesProteomicsDepressionMorphineMappingMosaicMicroRNAsCertainBacterialRecombinant
(Date:11/24/2009)... Physician recruiting firm LocumT...an staffing, is pleased to announce its agreement ...rovide physicians for locum tenens assignments. ,...vember 24, 2009 -- Physician recruiting firm Lo...ysician staffing, is pleased to announce its agree...
(Date:11/24/2009)... The molecular cause of inflammat... will be presented at the upcoming 2009 Advances i...amp; Colitis Foundation’s Clinical & Res...da, that may identify a causative mutation for Cro... York, NY (Vocus) November 24, 2009 -- The molecul...
(Date:11/24/2009)...HARRISBURG,Pa.,Nov.24/PRNewswire-USNewswire/--Gove...lvaniansat-riskfortheH1N1fluwerevaccinatedduringth...Healthandlocalhealthdepartments. ,, "Withthefed...rojectionsregardingtheavailabilityofH1N1vaccine,di..."Overall,wearepleasedwiththeH1N1vaccinedistributio...
(Date:11/24/2009)...SANTACLARA,Calif.,Nov.24/PRNewswire/--AgitoNetwork...terprisemobility,todayannouncedthatitwashonoredint...sAgitoRoamAnywhereMobilityRouterv3.0.EverythingCha...sthathaveintroducednewsolutionsthatdriveadvancesth...nel,sTestCenterreviewedhundredsofapplicationsforth...
(Date:11/24/2009)...SANBERNARDINO,Calif.,Nov.24/PRNewswire/--Nextmonth...seminarsaimedathelpingHispanic-Americanseniorsunde...orsareencouragedtotakeafreeZumba®Goldclass,aL...rengue,salsa,cumbia,rumba,andtango. ,, UnitedHe...ntsfeelcomfortableandengagedwhenlearningabouttheir...
Breaking Medicine News(10 mins):Health News:VHA Names LocumTenens.com as Preferred Physician Staffing Vendor 2Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 2Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 3Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 4Health News:Governor Rendell Announces 100,000 At-Risk Pennsylvanians Vaccinated at H1N1 Public Health Clinics; Addresses Future Vaccine Distribution Plans 2Health News:Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel 2Health News:Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel 3Health News:UnitedHealthcare To Offer Seniors Hispanic-Centered Medicare Education Seminars Combined With a Latin-Themed Fitness Program 2[0] VHA Names LocumTenens.com as Preferred Physician Staffing Vendor[2] Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research[0] Governor Rendell Announces 100,000 At-Risk Pennsylvanians Vaccinated at H1N1 Public Health Clinics; Addresses Future Vaccine Distribution Plans[2] Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel[1] UnitedHealthcare To Offer Seniors Hispanic-Centered Medicare Education Seminars Combined With a Latin-Themed Fitness Program
(Date:11/23/2009)...iated strain of the deadly superbug MRSAan infecti...ioticsposes a far greater health threat than previ...according to a study in the December issue of Eme... easily picked up in fitness centers, schools, and... burden of MRSA within hospitals, the report found...
(Date:11/23/2009)...ests that a common oral bacterium may exacerbate a...et al, "Unique Lipids from a Common Human Bacteriu... Enhancing Autoimmunity," appears in the December ... , Multiple sclerosis (MS), a disease where the ...ffects nearly 1 in 700 people in the United States...
(Date:11/23/2009)...University of Alabama at Birmingham (UAB) research...ng medical conditions (co-morbidity) do not explai...ericans compared to Caucasians who also have colon... Cancer , a journal of the American Cancer Society...co-morbidity are independent predictors of poor su...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2Factors from common human bacteria may trigger multiple sclerosis 2Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Care Tech Laboratories Agrees to Stop Making Selling and Distributing Unapproved Antimicrobial Products 56497 1Care Tech Laboratories Agrees to Stop Making Selling and Distributing Unapproved Antimicrobial Products 56497 2Nepali Home Minister Commends Narconon International for Saving Lives 56495 1Nepali Home Minister Commends Narconon International for Saving Lives 56495 2The Dr Oz Show Names Core Team Oz 56493 1The Dr Oz Show Names Core Team Oz 56493 2The Dr Oz Show Names Core Team Oz 56493 3The Dr Oz Show Names Core Team Oz 56493 4| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |